Tucatinib,Trastuzumab,fulvestrant
Seagen
['trametinib', 'dabrafenib', 'milestone,(-milestones)']
 in the context of plenary on brain tumor #asco23 sharing a major milestone in the #precisionmedicine for braf + glioblastoma &amp; the first ever positive targeted therapy for brain tumors. dabrafenib + trametinib in brafv600e-mutant low-grade &amp; high-grade glioma 
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.